ArriVent Biopharma raises $155M in one of largest local funding rounds of 2023

Newtown Square-based Arrivent Biopharm, which is looking to bring Chinese drug products to the United States, launched in 2021.

LocalNews LocalNews
Mar 28, 2023 - 00:00
0 28
ArriVent Biopharma raises $155M in one of largest local funding rounds of 2023
Newtown Square-based Arrivent Biopharm, which is looking to bring Chinese drug products to the United States, launched in 2021.
Read More